Paul W. Hoelscher - Jan 20, 2022 Form 4 Insider Report for Reneo Pharmaceuticals, Inc. (RPHM)

Role
Director
Signature
/s/ Vineet R. Jindal, Attorney-in-Fact
Stock symbol
RPHM
Transactions as of
Jan 20, 2022
Transactions value $
$0
Form type
4
Date filed
1/24/2022, 03:58 PM
Previous filing
Jan 6, 2022
Next filing
Jan 24, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RPHM Stock Option (right to buy) Award $0 +35K $0.00 35K Jan 20, 2022 Common Stock 35K $8.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the stock option vest and become exercisable in equal monthly installments over a three-year period.